8-K
filed July 14, 2023, 7:59 PM ET
ticker REVB
CIK 0001810560
other
confidence high
sentiment neutral
materiality 0.15
Revelation Biosciences stockholders elect directors, approve equity plan increase, ratify auditor
REVELATION BIOSCIENCES, INC.
- Quorum of 2,309,314 shares (>1/3 of 5,773,983 outstanding) present or proxy.
- Directors Jennifer Carver (1,281,109 for) and Curt LaBelle (1,280,290 for) elected to Class A.
- Approved amendment to 2021 Equity Incentive Plan: shares reserved increased from 68,288 to 648,678 (1,124,336 for).
- Ratified Baker Tilly US, LLP as auditor for fiscal year ending Dec 31, 2023 (1,981,630 for).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REVELATION BIOSCIENCES, INC. shareholders approved Ratification of the Auditor at the 2023-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-31
Exact text from the filing
Stockholders approved Baker Tilly US, LLP to audit our financial statements for the fiscal year ending December 31, 2023, based on the votes listed below: For Against Abstain 1,981,630 26,027 301,657
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REVELATION BIOSCIENCES, INC. shareholders approved Approval of to increase he number of shares reserved under the Company’s 2021 Equity Incentive Plan.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
Stockholders approved an amendment to the 2021 Equity Incentive Plan to increase the number of shares reserved under the Plan from 68,288 to 648,678, based on the votes listed below: For Against Abstain 1,124,336 224,337 15,961
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
REVELATION BIOSCIENCES, INC. shareholders approved Election of Directors.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
Stockholders approved to elect the two nominees for Class A director named herein to serve until the 2026 Annual Meeting or their successors are duly elected and qualified., based on the votes listed below: Director Nominee For Against Abstain Jennifer Carver 1,281,109 68,257 15,268 Curt LaBelle 1,280,290 66,949 17,395
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.